Cargando…
Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy
BACKGROUND: Time-dependent chemotherapeutic agents can selectively target tumor cells in susceptible phases of the cell cycle however a fraction of tumor cells in non-vulnerable cell cycle phases remain drug-resistant. Immunotherapy represents a promising approach to overcome the limitation of phase...
Autores principales: | Alagkiozidis, Ioannis, Facciabene, Andrea, Tsiatas, Marinos, Carpenito, Carmine, Benencia, Fabian, Adams, Sarah, Jonak, Zdenka, June, Carl H, Powell, Daniel J, Coukos, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118128/ https://www.ncbi.nlm.nih.gov/pubmed/21609494 http://dx.doi.org/10.1186/1479-5876-9-77 |
Ejemplares similares
-
Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18
por: Alagkiozidis, Ioannis, et al.
Publicado: (2009) -
Distinct Effects of IL-18 on the Engraftment and Function of Human Effector CD8(+) T Cells and Regulatory T Cells
por: Carroll, Richard G., et al.
Publicado: (2008) -
Whole tumor antigen vaccination using dendritic cells: Comparison of RNA electroporation and pulsing with UV-irradiated tumor cells
por: Benencia, Fabian, et al.
Publicado: (2008) -
Toll-like Receptors in Ovarian Cancer as Targets for Immunotherapies
por: Muccioli, Maria, et al.
Publicado: (2014) -
Know thy enemy: Why are tumor-infiltrating regulatory T cells so deleterious?
por: Facciabene, Andrea, et al.
Publicado: (2012)